ALPIX — Pixium Vision SA Share Price
- €0.52m
- €5.28m
- €1.96m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.29 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -637% |
Financial Summary
Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 1.6 | 1.78 | 2.09 | 2.65 | 1.96 | 1.8 | 0.8 | -5.07% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Pixium Vision SA is a France-based company that specializes in sensory neuromodulation. The Company is focused on the development of implantable medical devices for the treatment of blindness caused by degeneration of photoreceptor cells in the retina. The Company develops two Vision Restoration Systems (VRS) platforms, including IRIS and PRIMA. The Company’s implant technology replaces the signal processing functions in the retina by electrically stimulating the retinal cells, enabling them to transmit the stimulation signals to the brain’s visual cortex via the optic nerve, and its other systems initially enables patients with retinitis pigmentosa to partially recover their vision. The Company has collaboration with technology and academic institutions, including the Institut de la Vision (Paris), Universite Pierre et Marie Curie (Paris), Stanford University (the United States) and University of Ulm (Germany).
Directors
- Bernard Gilly CHM
- Lloyd Diamond CEO (51)
- Offer Nonhoff CFO
- Guillaume Buc CTO
- Karine Chevrie OTH
- Ralf Hornig OTH
- Gerard Hascoet DRC
- Olivia Le Proux de la Riviere DRC
- Marie Meynadier IND
- Robert ten Hoedt IND (61)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- December 14th, 2011
- Public Since
- June 19th, 2014
- No. of Employees
- 42
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Euronext - Paris
- Shares in Issue
- 1,385,739.34

- Address
- 74 rue du Faubourg Saint-Antoine, PARIS, 75012
- Web
- https://www.pixium-vision.com/
- Phone
- +33 176214768
- Contact
- Lloyd Diamond
- Auditors
- Deloitte & Associes
Upcoming Events for ALPIX
Pixium Vision SA Annual Shareholders Meeting
Similar to ALPIX
Affluent Medical SAS
Euronext - Paris
Alpha MOS SA
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
Biosynex SA
Euronext - Paris
FAQ
As of Today at 18:17 UTC, shares in Pixium Vision SA are trading at €0.38. This share price information is delayed by 15 minutes.
Shares in Pixium Vision SA last closed at €0.38 and the price had moved by -88.63% over the past 365 days. In terms of relative price strength the Pixium Vision SA share price has underperformed the FTSE Global All Cap Index by -89.44% over the past year.
The overall consensus recommendation for Pixium Vision SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out morePixium Vision SA does not currently pay a dividend.
Pixium Vision SA does not currently pay a dividend.
Pixium Vision SA does not currently pay a dividend.
To buy shares in Pixium Vision SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.38, shares in Pixium Vision SA had a market capitalisation of €0.52m.
Here are the trading details for Pixium Vision SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALPIX
Based on an overall assessment of its quality, value and momentum Pixium Vision SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Pixium Vision SA is €45.00. That is 11855.37% above the last closing price of €0.38.
Analysts covering Pixium Vision SA currently have a consensus Earnings Per Share (EPS) forecast of -€4.50 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pixium Vision SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -86.65%.
As of the last closing price of €0.38, shares in Pixium Vision SA were trading -79.37% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Pixium Vision SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Pixium Vision SA's management team is headed by:
- Bernard Gilly - CHM
- Lloyd Diamond - CEO
- Offer Nonhoff - CFO
- Guillaume Buc - CTO
- Karine Chevrie - OTH
- Ralf Hornig - OTH
- Gerard Hascoet - DRC
- Olivia Le Proux de la Riviere - DRC
- Marie Meynadier - IND
- Robert ten Hoedt - IND